ライフサイエンスコーパス: wedge pressure

1 ly used variables (i.e. mixed venous oxygen, wedge pressure).

2 rdiac filling pressures (pulmonary capillary wedge pressure).

3 nary artery pressure and pulmonary capillary wedge pressure.

4 pressure, heart rate, or pulmonary capillary wedge pressure.

5 orse symptoms and higher pulmonary capillary wedge pressure.

6 and severity of emphysema, and directly with wedge pressure.

7 ar resistance as well as pulmonary capillary wedge pressure.

8 ar systolic pressure and pulmonary capillary wedge pressure.

9 elocities for estimating pulmonary capillary wedge pressure.

10 ic filling, despite high pulmonary capillary wedge pressure.

11 lmonary artery pressure and pulmonary artery wedge pressure.

12 nary artery pressure and pulmonary capillary wedge pressure.

13 ctional flow reserve and increasing coronary wedge pressure.

14 ltaneous measurements of pulmonary capillary wedge pressure.

15 patient age, and varying pulmonary capillary wedge pressure.

16 ction in mean pulmonary artery and pulmonary wedge pressures.

17 nge systemic arterial or pulmonary capillary wedge pressures.

18 t, 11.4+/-3.3 L/min; and pulmonary capillary wedge pressure, 13+/-4 mm Hg.

19 in, p < 0.01), increased pulmonary capillary wedge pressure (17 +/- 7 vs. 14 +/- 6 mm Hg, p < 0.002)

20 g; P=0.0002), and higher pulmonary capillary wedge pressure (17+/-5 versus 9+/-3 mm Hg; P=0.0001).

21 m Hg to 98 +/- 13 mm Hg; pulmonary capillary wedge pressure: 17 +/- 6 mm Hg to 21 +/- 7 mm Hg; cardia

22 s. 108 +/- 14 mm Hg) and pulmonary capillary wedge pressure (18 +/- 2 vs. 12 +/- 4 mm Hg) versus prei

23 -4 mm Hg; P=0.0001), and pulmonary capillary wedge pressure (18+/-5 versus 10+/-4 mm Hg; P<0.0001) co

24 mg significantly reduced pulmonary capillary wedge pressure (-2.6+/-0.7, -5.4+/-0.7, and -4.6+/-0.7 m

25 tric LVH and estimated mean pulmonary artery wedge pressure (20 mm Hg vs. 16 mm Hg) and shorter isovo

26 p < 0.01 by ANOVA) and mean pulmonary artery wedge pressure (21+/-3 to 16+/-2 mm Hg, p < 0.05 by ANOV

27 arly reductions were sustained for pulmonary wedge pressure (24+/-9 to 15+/-5 mm Hg early; 12+/-6 mm

28 +/-2 mm Hg; P<0.05), and pulmonary capillary wedge pressure (25+/-2 to 20+/-2 mm Hg; P<0.05).

29 produced significant reductions in pulmonary wedge pressure (27% to 39% decrease by 6 h), mean right

30 s. 16 +/- 8 mm Hg, p = 0.007, mean pulmonary wedge pressure: 27 +/- 8 mm Hg vs. 20 +/- 7 mm Hg, p = 0

31 s. 13 mm Hg; p = 0.001), pulmonary capillary wedge pressure (29 vs. 24 mm Hg; p = 0.001), but similar

32 pressure (18+/-2 to 7+/-1 mm Hg), pulmonary wedge pressure (32+/-3 to 15+/-2 mm Hg), and systemic va

33 vascular resistance 25%, pulmonary capillary wedge pressure 33%, and central venous pressure 27% whil

34 nitrite reduced resting pulmonary capillary wedge pressure (-4+/-3 versus -1+/-2 mm Hg; P=0.002), im

35 uctions in 0-hour trough pulmonary capillary wedge pressure (-4.3 mm Hg; P=0.16), pulmonary artery di

36 sulted in an increase in pulmonary capillary wedge pressure (54 +/- 78% vs. 32 +/- 26%, p = NS), card

37 es significantly reduced pulmonary capillary wedge pressure (-6.4 +/- 4.1 mm Hg, -5.7 +/- 4.6 mm Hg,

38 icacy end point included pulmonary capillary wedge pressure (72 to 96 hours) and days alive out of ho

39 of ADMA correlated with pulmonary capillary wedge pressure and both systolic and diastolic pulmonary

40 monary arterial pressure, pulmonary arterial wedge pressure and cardiac output.

41 e actual R(micro) and IMR after the coronary wedge pressure and collateral flow were incorporated int

42 -confirmed PH with elevated pulmonary artery wedge pressure and low pulmonary vascular resistance, we

43 ight atrial pressure and pulmonary capillary wedge pressure and lower cardiac index (CI) but not Paco

44 Pulmonary capillary wedge pressure and LV end-diastolic pressure were signif

45 ssure-volume curves from pulmonary capillary wedge pressure and LV end-diastolic volume and Starling

46 Pulmonary capillary wedge pressure and LV end-diastolic volume were measured

47 d normative responses of pulmonary capillary wedge pressure and mean pulmonary arterial pressure to v

48 the largest increases in pulmonary capillary wedge pressure and mean pulmonary arterial pressure.

49 the presence of a normal pulmonary capillary wedge pressure and portal hypertension, is a known compl

50 dose-dependently reduced pulmonary capillary wedge pressure and pulmonary and systemic vascular resis

51 ulmonary exercise tests, pulmonary capillary wedge pressure and serum sodium were strong predictors o

52 and Starling curves from pulmonary capillary wedge pressure and SV during lower body negative pressur

53 c output, stroke volume, pulmonary capillary wedge pressure and systemic vascular resistance.

54 ary artery catheter use, pulmonary capillary wedge pressure and the incidence of diabetes mellitus an

55 d significant inverse correlations with mean wedge pressure and time constant of LV relaxation.

56 Pulmonary capillary wedge pressures and left ventricular end-diastolic volum

57 Pulmonary capillary wedge pressures and LV end-diastolic volumes were measur

58 re, pulmonary vascular resistance, capillary wedge pressure, and cardiac index were also obtained at

59 Increased cardiac output, decreased wedge pressure, and decreased brain natriuretic peptide

60 cardiac output, decrease pulmonary capillary wedge pressure, and reduce pulmonary and systemic vascul

61 cardiac index, elevated pulmonary capillary wedge pressure, and renal impairment or substantial diur

62 Primary end point was pulmonary capillary wedge pressure, and secondary end points comprised cardi

63 diac output, heart rate, pulmonary capillary wedge pressure, and systemic vascular resistance were me

64 Higher pulmonary capillary wedge pressure appears to enhance net right ventricular

65 s that pulmonary artery and pulmonary artery wedge pressures are higher in SIPE-susceptible individua

66 tly greater reduction in pulmonary capillary wedge pressure at 3, 4, and 8 hours and during the presp

67 was no effect of age on pulmonary capillary wedge pressure at any point throughout the cardiac cycle

68 r than 40%, and a raised pulmonary capillary wedge pressure at rest (>15 mm Hg) or during exercise (>

69 e were no differences in pulmonary capillary wedge pressure at rest (13+/-4 versus 13+/-3 mm Hg, P=0.

70 d with directly measured pulmonary capillary wedge pressure at rest (r=0.63, P<0.0001) and during exe

71 ients had a reduction in pulmonary capillary wedge pressure at rest, 34 (58%) of 59 had a lower pulmo

72 y be changed by elevated pulmonary capillary wedge pressure, augmenting right ventricular pulsatile l

73 ose-related decreases in pulmonary capillary wedge pressure (average change -5.9+/-0.9 mm Hg and -5.3

74 ulmonary artery pressure or pulmonary artery wedge pressure between SIPE-susceptible subjects and con

75 roving cardiac index and pulmonary capillary wedge pressure, but statistical significance for the pri

76 ram per minute decreased pulmonary-capillary wedge pressure by 6.0 and 9.6 mm Hg, respectively (as co

77 systemic blood pressure, pulmonary capillary wedge pressure, cardiac index, and estimated glomerular

78 mean arterial pressure, pulmonary capillary wedge pressure, cardiac index, or systemic vascular resi

79 gnificant differences in pulmonary capillary wedge pressure, cardiac output, pulmonary vascular resis

80 artery, right atrial and pulmonary capillary wedge pressures, cardiac index, systemic and pulmonary v

81 al, pulmonary artery, or pulmonary capillary wedge pressures; cardiac index; respiratory rate; or hea

82 11; LVAD, 18+/-4 mm Hg) and pulmonary artery wedge pressure (CHF, 16+/-10; LVAD 5+/-3 mm Hg) were red

83 , 30+/-5 mm Hg) and mean pulmonary capillary wedge pressure (CHF, 31+/-11; LVAD, 14+/-6 mm Hg) were l

84 ated LV end-diastolic or pulmonary capillary wedge pressure, consistent with diastolic dysfunction, w

85 as the inverse was true for pulmonary artery wedge pressure (corresponding muPAWP were 21.5, 16.5, an

86 (-2)]; P<0.001) and mean pulmonary capillary wedge pressure decreased (from 15 mm Hg [IQR, 12-20 mm H

87 48 hours after implant, pulmonary capillary wedge pressure decreased 44%, systemic vascular resistan

88 decreased 19% (P=0.03), pulmonary capillary wedge pressure decreased 46% (P=0.002), and mean arteria

89 iac index increased 43%, pulmonary capillary wedge pressure decreased 52%, systemic vascular resistan

90 The pulmonary wedge pressure decreased during exercise, consistent wit

91 25.9 +/- 1.7 mm Hg; mean pulmonary capillary wedge pressure decreased from 25.1 +/- 1.1 to 13.2 +/- 1

92 Pulmonary capillary wedge pressure decreased from 28.5+/-4.9 to 19.8+/-7.0 m

93 Pulmonary capillary wedge pressure decreased from 28.8+/-6.3 mm Hg (mean+/-S

94 Pulmonary capillary wedge pressure* decreased to a larger extent with F+T th

95 sion (n=1009) and normal pulmonary capillary wedge pressure displayed a consistent R(PA)-C(PA) hyperb

96 rimary end point was the pulmonary capillary wedge pressure during exercise.

97 (58%) of 59 had a lower pulmonary capillary wedge pressure during exertion, and 23 (39%) of 59 fulfi

98 (9+/-2 mm Hg) displayed pulmonary capillary wedge pressure elevation (P=0.03).

99 Exercise elicits greater pulmonary capillary wedge pressure elevation compared with saline in HFpEF b

100 Mean pulmonary wedge pressure fell from 31 to 18 mm Hg, right atrial pr

101 p < 0.01) and increased pulmonary capillary wedge pressure (from 25 +/- 2 to 29 +/- 3 mm Hg, p < 0.0

102 is predictive of a mean pulmonary capillary wedge pressure greater than 15 mm Hg with a 92% sensitiv

103 ction 21+/-1%) who had a pulmonary capillary wedge pressure >/=15 mm Hg and a cardiac index </=2.5 L

104 Patients with a baseline pulmonary capillary wedge pressure >/=15 mm Hg and a cardiac index </=2.5 L.

105 ventricular [RV] DD) or pulmonary capillary wedge pressure >/=18 mm Hg (left ventricular [LV] DD) wi

106 pressure <100 mm Hg and pulmonary capillary wedge pressure >/=24 mm Hg and dependent on >/=2 inotrop

107 ients in MI+DD (29%) had pulmonary capillary wedge pressure >15 (14+/-4 mm Hg), whereas none of the M

108 identified patients with pulmonary capillary wedge pressure >15 mm Hg (area under the curve: 0.73 to

109 ubgroups: (1) patients with pulmonary artery wedge pressure >15 mm Hg; (2) pulmonary vascular resista

110 ic balloon pump support, pulmonary capillary wedge pressure >20 mm Hg and serum creatinine >1.5 mg/dl

111 on class II-IV, elevated pulmonary capillary wedge pressure (>/=15 mm Hg at rest or >/=25 mm Hg durin

112 ise, an abnormal rise in pulmonary capillary wedge pressure (>25 mm Hg) was observed in 94% of MI+DD

113 80% of predicted and peak pulmonary arterial wedge pressure>/=20 mm Hg) with 31 age- and sex-matched

114 y, ratio of right atrial/pulmonary capillary wedge pressure, hemoglobin) was created.

115 0.022), diastolic PAP - pulmonary capillary wedge pressure (HR, 2.19; 95% CI, 1.23-3.89 per 10 mm Hg

116 eart failure to decrease pulmonary capillary wedge pressure, improve cardiac output, stimulate natriu

117 The mean pulmonary capillary wedge pressure in patients with PHTN was higher than tha

118 In healthy subjects, pulmonary capillary wedge pressure increased from 10+/-2 to 16+/-3 mm Hg aft

119 Mean pulmonary capillary wedge pressure increased from 9.3 +/- 3.2 mm Hg to 10.6

120 y arterial pressure, and pulmonary capillary wedge pressure increased similarly with saline and exerc

121 Right atrial and pulmonary capillary wedge pressures increased from 6 +/- 4 and 5 +/- 3 mm Hg

122 rease stroke volume when pulmonary capillary wedge pressure is lowered with vasodilators.

123 volume overload, a treatment-induced drop in wedge pressure is often accompanied by a rapid drop in N

124 ch as ejection fraction, cardiac output, and wedge pressure, is available, but also in clinical trial

125 d-diastolic pressures and pulmonary arterial wedge pressures, is associated with remarkably increased

126 The pulmonary capillary wedge pressure, lactic acid level, and creatinine level

127 ndex, ejection fraction, pulmonary capillary wedge pressure, left ventricular dimensions, watts achie

128 s x second x cm(-5), and pulmonary capillary wedge pressure < or = 15 mm Hg.

129 pressure >/=25 mm Hg and pulmonary capillary wedge pressure </=15 mm Hg at right heart catheterizatio

130 crimination between mean pulmonary capillary wedge pressure </=15 versus >15 mm Hg.

131 pressure >/=25 mm Hg and pulmonary capillary wedge pressure </=15mm Hg).

132 furosemide, mannitol (if pulmonary capillary wedge pressure <20 mm Hg), and low-dose dopamine (n = 43

133 scular resistance, >3.0 WU; pulmonary artery wedge pressure, </=15 mm Hg).

134 tage have revealed a normal pulmonary artery wedge pressure, marked elevation of pulmonary artery pre

135 the true IMR (IMR(true)), which incorporates wedge pressure measurement to account for collateral flo

136 th Revision procedure codes describing PA or wedge-pressure monitoring, measurement of mixed venous b

137 owever, elevation of the pulmonary capillary wedge pressure (n=8142) had a larger impact, significant

138 versus 32 +/- 12%) and mean pulmonary artery wedge pressure of < or = 18 versus > 18 mm Hg (84 +/- 6%

139 wo post-CBC variables: mean pulmonary artery wedge pressure of < or = 18 versus > 18 mm Hg (90 +/- 6%

140 dex (2.4 liters/min.m2), pulmonary capillary wedge pressure of 16 +/- 9 mm Hg (mean +/- SD) and maxim

141 ter, 127 patients with a pulmonary-capillary wedge pressure of 18 mm Hg or higher and a cardiac index

142 re of 40.5+/-11.4 mm Hg, pulmonary capillary wedge pressure of 22.6+/-8.9 mm Hg, and pulmonary vascul

143 x of 1.7 L/min per m(2), pulmonary capillary wedge pressure of 25.6 mm Hg, and left ventricular eject

144 c filling volume was the pulmonary capillary wedge pressure of the seniors lower than that of the you

145 ic pressure (P = 0.001) and pulmonary artery wedge pressure (P = 0.009).

146 0.02, r = 0.83), higher pulmonary capillary wedge pressure (p = 0.01, r = 0.58) and lower cardiac in

147 08, r = 0.88) and higher pulmonary capillary wedge pressure (p = 0.02, r =0.54).

148 kload corrected exercise pulmonary capillary wedge pressure (P<0.01).

149 al pressure (P=0.36) and pulmonary capillary wedge pressure (P=0.53) were not.

150 y reduced pulmonary arterial (p < 0.001) and wedge pressures (p < 0.01) and pulmonary vascular resist

151 dynamic profiles, including higher pulmonary wedge pressures (P=0.002) and lower cardiac indexes (P<0

152 dilatation, increase of pulmonary capillary wedge pressure, PAP and RAP were more pronounced in AF t

153 related to the use of mean pulmonary artery wedge pressure (PAWP).

154 ly correlated with supine pulmonary arterial wedge pressure (PAWP; r=0.36; P<0.001) and demonstrated

155 isease (PH(PVD), defined as pulmonary artery wedge pressure [PAWP]</=15 mm Hg and PVR>3 WU).

156 PEEP can dissociate wedge pressure (Pcw) from transmural left atrial pressur

157 intraarterial catheter, pulmonary capillary wedge pressure (Pcw), continuous cardiac output (Q), and

158 =2.5 l/min per m(2) and pulmonary capillary wedge pressure (PCWP) > or =15 mm Hg) who were admitted

159 ssure (RAP) >12 mm Hg or pulmonary capillary wedge pressure (PCWP) >15 mm Hg were analyzed.

160 nine (2.6 to 1.5 mg/dL), pulmonary capillary wedge pressure (PCWP) (32 to 14 mm Hg), and right atrial

161 by baseline measures of pulmonary capillary wedge pressure (PCWP) and cardiac index (CI), and by cha

162 ficant increases in both pulmonary capillary wedge pressure (PCWP) and central venous pressure (CVP).

163 sitive relationship with pulmonary capillary wedge pressure (PCWP) and left ventricular end-diastolic

164 ns were observed between pulmonary capillary wedge pressure (PCWP) and sole parameters of mitral flow

165 subjects for measures of pulmonary capillary wedge pressure (PCWP) and SV (thermodilution derived car

166 trial pressure (RAP) and pulmonary capillary wedge pressure (PCWP) are correlated in heart failure, i

167 n the prospective group, pulmonary capillary wedge pressure (PCWP) derived as: PCWP(Doppler) = LV(end

168 hy, BNP measurement, and pulmonary capillary wedge pressure (PCWP) determination.

169 Increases in pulmonary capillary wedge pressure (PCWP) develop in patients with HFpEF dur

170 has been correlated with pulmonary capillary wedge pressure (PCWP) in a wide variety of cardiac condi

171 s noninvasive markers of pulmonary capillary wedge pressure (PCWP) in the setting of critical illness

172 invasive measurement of pulmonary capillary wedge pressure (PCWP) simultaneous with Doppler echocard

173 d ePVH groups had higher pulmonary capillary wedge pressure (PCWP) than the ePH group (P < 0.05).

174 Pulmonary capillary wedge pressure (PCWP) was estimated from the ratio of ea

175 ary artery pressure, and pulmonary capillary wedge pressure (PCWP) were recorded.

176 ion fraction, 22 +/- 9%; pulmonary capillary wedge pressure (PCWP), 16 +/- 10 mm Hg; cardiac index (C

177 c nerve activity (RSNA), pulmonary capillary wedge pressure (PCWP), and mean arterial pressure (MAP)

178 in eight males from whom pulmonary capillary wedge pressure (PCWP), central venous pressure and SV (v

179 ressure, as expressed by pulmonary capillary wedge pressure (PCWP), during lower-body negative pressu

180 as associated with lower pulmonary capillary wedge pressure (PCWP), fewer symptoms, and greater quali

181 We measured pulmonary capillary wedge pressure (PCWP), SV, left ventricular end-diastoli

182 es of istaroxime lowered pulmonary capillary wedge pressure (PCWP), the primary end point (mean +/- S

183 cant relations with mean pulmonary capillary wedge pressure (PCWP).

184 etween the reductions in pulmonary capillary wedge pressure (PCWP; 25.4, 24.6, 24.0, 23.5, 23.4, 21.5

185 ardiographic indices and pulmonary capillary wedge pressures (PCWP) in normal volunteers.

186 Pulmonary capillary wedge pressure, pulmonary arterial pressure, stroke volu

187 y linear regression with pulmonary capillary wedge pressure (pw).

188 rom pulmonary venous hypertension (PVH) by a wedge pressure (PWP)>15 mm Hg in PVH.

189 aphic severity correlated significantly with wedge pressure (r = 0.93, P < .001) and pulmonary arteri

190 rong inverse relation with PVR (r=-0.64) and wedge pressure (r=-0.73), and provides stronger predicti

191 tly with changes in mean pulmonary capillary wedge pressure (r=0.63, P<0.001).

192 VR) ratio had the best correlation with mean wedge pressure (r=0.79, P<0.001), as well as in 24 prosp

193 els correlated with mean pulmonary capillary wedge pressure (r=0.82, P=0.007).

194 ed a steeper increase in pulmonary capillary wedge pressure relative to infused volume (25+/-12 mm Hg

195 ed a steeper increase in pulmonary capillary wedge pressure relative to volume infused (16+/-4 mm Hg.

196 n mean pulmonary artery and pulmonary artery wedge pressures, respectively, but no change in transpul

197 and it had no effect on pulmonary-capillary wedge pressure, right atrial pressure, heart rate, or ca

198 LV transmural pressure (pulmonary capillary wedge pressure-right atrial pressure), which reflects LV

199 trans-septal gradient (=pulmonary capillary wedge pressure-right atrial pressure; r=0.67; P=0.003),

200 The mean pulmonary capillary wedge pressure rose from 25+/-14 to 36+/-9 mm Hg (P:=0.0

201 in pulmonary artery and pulmonary capillary wedge pressures, suggesting abnormal compliance, with ma

202 c output, stroke volume, pulmonary capillary wedge pressure, systemic and pulmonary vascular resistan

203 g pulmonary arterial and pulmonary capillary wedge pressures than the remaining heart-failure patient

204 d pulmonary arterial and pulmonary capillary wedge pressures to a greater level than OMA alone or ACE

205 ure was > 20 mm Hg; in 61.4%, end-expiratory wedge pressure was > 12 mm Hg.

206 The pulmonary artery wedge pressure was </=15 mm Hg in 54%, indicating that l

207 004), and the corresponding pulmonary artery wedge pressure was 11.0 mm Hg versus 18.8 mm Hg (P=0.028

208 as 8.5 (6-18) mm Hg, and pulmonary capillary wedge pressure was 18 (14-21) mm Hg.

209 L . min(-)(1) . m(-)(2), pulmonary capillary wedge pressure was 31.5 +/- 5.7 mm Hg, and heart failure

210 . kg(-)(1) . min(-)(1), pulmonary capillary wedge pressure was 5.9 +/- 4.6 mm Hg, and cardiac index

211 m Hg and between PVP and pulmonary capillary wedge pressure was 7.5 mm Hg.

212 Pulmonary capillary wedge pressure was correlated with body mass and plasma

213 vascular resistance and pulmonary capillary wedge pressure was evident at 3 min after infusion in 70

214 Mean exercise pulmonary capillary wedge pressure was lower at 6 months than at baseline, b

215 Pulmonary capillary wedge pressure was reduced from a mean of 23 mm Hg (SD 5

216 r for the two groups but pulmonary capillary wedge pressure was slightly lower for Group C (22 vs. 24

217 administration, exercise pulmonary capillary wedge pressure was substantially improved by nitrite as

218 espectively; and Pw referred to the coronary wedge pressure, was also measured.

219 tion with measurement of pulmonary capillary wedge pressure waveform during 5 different loading condi

220 detailed analysis of the pulmonary capillary wedge pressure waveform obtained by right-heart catheter

221 ar resistance and normal pulmonary capillary wedge pressure, we make a weak recommendation for either

222 vascular resistance and pulmonary capillary wedge pressure were decreased, as compared with untreate

223 The cardiac index and pulmonary-capillary wedge pressure were elevated in the six patients in whom

224 (r=0.947), while PVP and pulmonary capillary wedge pressure were found to be moderately correlated (r

225 ase-MB bands, troponin levels, and pulmonary wedge pressure were not elevated.

226 rtery pressure (PAP) and pulmonary capillary wedge pressure were obtained by standard techniques.

227 F, while pulmonary artery mean and pulmonary wedge pressures were similar.

228 displayed an increase in pulmonary capillary wedge pressure with exercise from 20+/-6 to 34+/-7 mm Hg

229 ubjects displayed higher pulmonary capillary wedge pressure with exercise, but this was solely becaus

230 diac output, and reduces pulmonary capillary wedge pressure without causing deleterious increases in